Analogs of caffeine: antagonists with selectivity for A2 adenosine receptors.
Several analogs of caffeine have been investigated as antagonists at A2 adenosine receptors stimulatory to adenylate cyclase in membranes from rat pheochromocytoma PC12 cells and human platelets and at A1 adenosine receptors inhibitory to adenylate cyclase from rat fat cells. Among these analogs, 1-propargyl-3,7-dimethylxanthine was about 4- to 7-fold and 7-propyl-1,3-dimethylxanthine about 3- to 4-fold more potent than caffeine at A2 receptors of PC12 cells and platelets. At A1 receptors of fat cells, both compounds were about 2-fold less potent than caffeine. These caffeine analogs have an A1/A2 selectivity ratio of about 10-20 and are the first selective A2 receptor antagonists yet reported. The results may provide the basis for the further development of highly potent and highly selective A2 adenosine receptor antagonists.
D000241:Adenosine / Q000031:analogs & derivatives / Q000037:antagonists & inhibitors; D019830:Adenosine-5'-(N-ethylcarboxamide); D000262:Adenylyl Cyclases / Q000378:metabolism; D000273:Adipose Tissue / Q000201:enzymology; D000310:Adrenal Gland Neoplasms / Q000201:enzymology; D000818:Animals; D001792:Blood Platelets / Q000201:enzymology; D002110:Caffeine / Q000031:analogs & derivatives* / Q000494:pharmacology; D006801:Humans; D010660:Phenylisopropyladenosine / Q000037:antagonists & inhibitors; D010673:Pheochromocytoma / Q000201:enzymology; D051381:Rats; D011956:Receptors, Cell Surface / Q000145:classification / Q000187:drug effects*; D011983:Receptors, Purinergic; D013329:Structure-Activity Relationship
D011956:Receptors, Cell Surface; D011983:Receptors, Purinergic; D010660:Phenylisopropyladenosine; D019830:Adenosine-5'-(N-ethylcarboxamide); D002110:Caffeine; D000262:Adenylyl Cyclases; D000241:Adenosine